Background: Concomitant prescription of anticholinergics with first generation antipsychotic medications is widely practiced in psychiatry to avert or abort extrapyramidal side effect resulting from the latter. Trihexyphenidyl (Benzhexol) is the most commonly prescribed and the most likely to be abused amidst the anticholinergics in Nigeria.
Objectives: To explore the prevalence and the associated factors for Trihexyphenidyl abuse among psychiatric outpatients in Nigeria.
Methodology: 64 stable outpatients who met the inclusion criteria were interviewed with a sociodemographic questionnaire and a ten items Drug Abuse Screening Test (DAST-10), other relevant data were obtained from their case notes at the psychiatric clinic of Sarkin Maska Shehu (SMASH) Hospital, Funtua, Katsina State. Data were tabulated and analysed with Microsoft Excel and version 11.65 of Window Program for Epidemiologist (WINPEPI).
Result: Mean age of participants was 36years, 33 (51.60%) of the participants were males, 24 (37.50%) were married while 36 (56.25%) were employed. Schizophrenia (38, 59.40%) was the leading axis 1 diagnoses among the studied participants. 16 (25.%) of the participants met the criteria for Trihexyphenidyl abuse.
Conclusion and Recommendations: Abuse potential of the Benzhexol and other anticholinergics calls for caution in its prescription amidst other disadvantages. Choice of atypical antipsychotics, gradual anticholinergic dose reduction, intermittent anticholinergic prescription and other ways were suggested to avert risk of abuse.
Keywords:
Published on: Mar 26, 2020 Pages: 3-8
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-3484.000029
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."